Phase II trial of sodium phenylbutyrate and taurursodiol in Wolfram syndrome

Fumihiko Urano; Bess A. Marshall; Stacy Hurst; Amy Robichaux-Viehoever; Saumel Ahmadi; Tamara Hershey; Gregory Van Stavern; Paulina Cruz Bravo; Jennifer Powers Carson; John Pesko; Kelly Fox; Nathalie Erpelding; Camille L. Bedrosian

doi:10.1172/JCI198519

Phase II trial of sodium phenylbutyrate and taurursodiol in Wolfram syndrome

Fumihiko Urano
, Bess A. Marshall
, Stacy Hurst
, Amy Robichaux-Viehoever
, Saumel Ahmadi
, Tamara Hershey
, Gregory Van Stavern
, Paulina Cruz Bravo
, Jennifer Powers Carson
, John Pesko
, Kelly Fox
, Nathalie Erpelding
, Camille L. Bedrosian

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

PB&TURSO was associated with improved or stabilized pancreatic function, vision, and overall symptom burden in individuals with Wolfram syndrome, a rare and progressive degenerative disease.

Original language	English
Article number	e198519
Journal	Journal of Clinical Investigation
Volume	136
Issue number	10
DOIs	https://doi.org/10.1172/JCI198519
State	Published - 2026

Access to Document

10.1172/JCI198519

Cite this

@article{749e65e93cd04b3d9fa862d402652735,

title = "Phase II trial of sodium phenylbutyrate and taurursodiol in Wolfram syndrome",

abstract = "PB\&TURSO was associated with improved or stabilized pancreatic function, vision, and overall symptom burden in individuals with Wolfram syndrome, a rare and progressive degenerative disease.",

author = "Fumihiko Urano and Marshall, \{Bess A.\} and Stacy Hurst and Amy Robichaux-Viehoever and Saumel Ahmadi and Tamara Hershey and \{Van Stavern\}, Gregory and Bravo, \{Paulina Cruz\} and Carson, \{Jennifer Powers\} and John Pesko and Kelly Fox and Nathalie Erpelding and Bedrosian, \{Camille L.\}",

year = "2026",

doi = "10.1172/JCI198519",

language = "English",

volume = "136",

journal = "Journal of Clinical Investigation",

issn = "0021-9738",

number = "10",

}

TY - JOUR

T1 - Phase II trial of sodium phenylbutyrate and taurursodiol in Wolfram syndrome

AU - Urano, Fumihiko

AU - Marshall, Bess A.

AU - Hurst, Stacy

AU - Robichaux-Viehoever, Amy

AU - Ahmadi, Saumel

AU - Hershey, Tamara

AU - Van Stavern, Gregory

AU - Bravo, Paulina Cruz

AU - Carson, Jennifer Powers

AU - Pesko, John

AU - Fox, Kelly

AU - Erpelding, Nathalie

AU - Bedrosian, Camille L.

PY - 2026

Y1 - 2026

N2 - PB&TURSO was associated with improved or stabilized pancreatic function, vision, and overall symptom burden in individuals with Wolfram syndrome, a rare and progressive degenerative disease.

AB - PB&TURSO was associated with improved or stabilized pancreatic function, vision, and overall symptom burden in individuals with Wolfram syndrome, a rare and progressive degenerative disease.

UR - https://www.scopus.com/pages/publications/105039335802

U2 - 10.1172/JCI198519

DO - 10.1172/JCI198519

M3 - Article

C2 - 42138079

AN - SCOPUS:105039335802

SN - 0021-9738

VL - 136

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

IS - 10

M1 - e198519

ER -

Phase II trial of sodium phenylbutyrate and taurursodiol in Wolfram syndrome

Abstract

Access to Document

Other files and links

Fingerprint

Cite this